ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,67%
Bitcoin
66 743,17
2,31%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Xencor Inc (XNCR)

  7. Xencor Inc (XNCR) Actualités

XNCR

Xencor (XNCR)

Xencor Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:XNCR
DateHeureSourceTitreSymboleSociété
09/05/202422h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XNCRXencor Inc
09/05/202422h09Business WireXencor Reports First Quarter 2024 Financial ResultsNASDAQ:XNCRXencor Inc
09/05/202422h02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XNCRXencor Inc
09/04/202414h01Business WireXencor Appoints Bart Cornelissen as Chief Financial OfficerNASDAQ:XNCRXencor Inc
11/03/202420h47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XNCRXencor Inc
07/03/202422h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XNCRXencor Inc
28/02/202422h01Business WireXencor to Present at Upcoming Investor ConferencesNASDAQ:XNCRXencor Inc
27/02/202422h01Business WireXencor Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:XNCRXencor Inc
20/02/202422h31Business WireXencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical UpdateNASDAQ:XNCRXencor Inc
16/02/202423h43Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XNCRXencor Inc
03/01/202422h01Business WireXencor to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:XNCRXencor Inc
02/01/202414h01Business WireDane Leone Joins Xencor as Senior Vice President, Corporate StrategyNASDAQ:XNCRXencor Inc
21/11/202322h01Business WireXencor to Present at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:XNCRXencor Inc
07/11/202322h01Business WireXencor Reports Third Quarter 2023 Financial ResultsNASDAQ:XNCRXencor Inc
07/11/202322h01Business WireXencor Sells Portion of Royalties and Milestones from Ultomiris® and Monjuvi® to OMERS Life Sciences for $215 MillionNASDAQ:XNCRXencor Inc
03/11/202317h01Business WireXencor Presents Preclinical Data from Multiple XmAb® Research Programs at the SITC Annual MeetingNASDAQ:XNCRXencor Inc
31/10/202321h01Business WireXencor to Host Third Quarter 2023 Financial Results Webcast and Conference Call on November 7, 2023NASDAQ:XNCRXencor Inc
26/10/202314h01Business WireXencor Announces Planned Retirement of Chief Financial Officer John KuchNASDAQ:XNCRXencor Inc
27/09/202315h01Business WireXencor to Present Multiple Posters at the SITC Annual MeetingNASDAQ:XNCRXencor Inc
19/09/202322h30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XNCRXencor Inc
19/09/202322h01Business WireXencor Appoints Barbara J. Klencke, M.D., to Board of DirectorsNASDAQ:XNCRXencor Inc
03/08/202322h01Business WireXencor Reports Second Quarter 2023 Financial ResultsNASDAQ:XNCRXencor Inc
27/07/202314h01Business WireXencor to Host Second Quarter 2023 Financial Results Webcast and Conference Call on August 3, 2023NASDAQ:XNCRXencor Inc
22/06/202323h56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XNCRXencor Inc
16/06/202316h55Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:XNCRXencor Inc
16/06/202316h42Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:XNCRXencor Inc
15/06/202312h05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XNCRXencor Inc
31/05/202300h01Business WireXencor Presents Clinical Results from Phase 1a Study of XmAb®564 at the EULAR 2023 CongressNASDAQ:XNCRXencor Inc
08/05/202323h16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XNCRXencor Inc
08/05/202322h01Business WireXencor Reports First Quarter 2023 Financial ResultsNASDAQ:XNCRXencor Inc
 Showing the most relevant articles for your search:NASDAQ:XNCR

Dernières Valeurs Consultées

LSE
365A
LSE
TRIN
Trinity Exploration & Pr...
EU
SSACG
Euronext S Credit Agrico...
BIT
I07619
Intesa Sanpaolo
COIN
FLETAUST
Fleta Token
ASE
G280722A2
Greece
LSE
0N8X
Casa Damiani
NYSE
FST
FAST Acquisition
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés